Neil Dahiya

The U.S. Food and Drug Administration (FDA) has expedited the approval process for two of Sanofi’s combined vaccine candidates that aim to protect individuals aged 50 and above from influenza and Covid-19. These candidates integrate existing vaccines that have demonstrated […]

Arvinas, Inc., a biotechnology company in clinical development phases, together with Pfizer Inc., disclosed initial findings from the phase 1b segment of the TACTIVE-U study. This study explores the efficacy of the vepdegestrant and abemaciclib combination in patients with locally

The Union Ministry of Ayush has announced a revision to the Drugs and Cosmetics Act of 1940, introducing the French Homoeopathic Pharmacopoeia and the European Pharmacopoeia as acceptable standards for the import and manufacture of homoeopathic medicines within India. Additionally,

The National Accreditation Board for Testing and Calibration Laboratories (NABL) has unveiled a broad array of amendments designed to refine its accreditation procedures and alleviate challenges faced by testing laboratories. This overhaul includes notable updates to the accreditation timeline, evaluation

After the Central government recently extended the completion period for developing the three bulk drug parks as part of the Scheme for Promotion of Bulk Drug Parks by an additional year, progress has been made in building all the designated

Universal Health Coverage (UHC) is designed to guarantee that everyone can access necessary healthcare services without financial strain. Achieving this goal means having a strong infrastructure and modern technology to provide patient-centered care. Every year on December 12, the global

The Siddha community across Tamil Nadu is set to commemorate Siddha Day on December 19 with great fervor. This annual event marks the birth anniversary of Sage Agastia, revered as the progenitor of the Siddha medical tradition. In Tamil Nadu,

The All India Pharmaceutical Association Consortium (AIPAC) has announced its inaugural programme, focused on enhancing the skills and scientific capabilities of pharmaceutical professionals, especially those from Micro, Small & Medium Enterprises (MSMEs). This initiative seeks to bolster knowledge and excellence

Amgen has declared the appointment of Naveen Gullapalli as its new managing director. He will oversee the operations at Amgen’s Technology and Innovation facility in Hyderabad, leveraging his broad expertise across pharmaceutical, finance, and tech sectors in guiding global operations

The World Ayurveda Congress 2024 (WAC 2024) will launch its 10th edition on December 12 in Dehradun, alongside the Arogya Expo, heralding a rejuvenation for the ancient Indian wellness approach. Focusing on the theme ‘Digital Health – An Ayurveda Perspective’,